The company’s board of directors approved a new $75M stock repurchase program. The 2025 repurchase program is in addition to the stock repurchase program approved by the board on August 2, 2016 providing for the repurchase of up to $50M of the company’s common stock.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OMCL:
- Omnicell narrows FY25 EPS view to $1.30-$1.65 from $1.00-$1.65
- Omnicell raises Q2 EPS view to 24c-34c from 19c-32c, consensus 25c
- Omnicell announces new products for perioperative and clinic settings
- Omnicell opens new Innovation Lab in Austin, Texas
- Omnicell upgraded to Overweight from Equal Weight at Wells Fargo